Liu Pharmaceutical Group and Huawei hold a high-level exchange discussion to explore cooperation in pharmaceutical intelligence.

According to information from the Liuyao Group, recently, the Liuyao Group held a high-level exchange forum with Huawei Technologies Co., Ltd. The two sides had in-depth discussions on topics such as the digital transformation of the pharmaceutical industry, the application of artificial intelligence, and supply chain optimization, aiming to further promote the implementation of strategic cooperation and jointly create a new benchmark for smart medicine.